PUBLICATIONS:

 

1.       Choi, Y.S., Lin, S.L., Lee, B., Naegele, J.R., Lombroso, P.L., and Obrietan, K. (2007).  Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase.  J. Neurosci. 27, 2999-3009.

 

2.       Navarro-Quiroga, I., Hernandez-Valdez, M., Lin, S.L., and Naegele, J.R. (2006).  Postnatal cellular contributions of the hippocampal subventricular zone to the dentate gyrus, corpus callosum, fimbria, and cerebral cortex.  J. Comp. Neurol. 497, 833-845.

 

3.       Neema, M., Navarro-Quiroga, I., Chechlacz, M., Gilliams-Francis, K., Liu, J., LaMonica, K., Lin, S.L., and Naegele, J.R. (2005).  DNA damage and non-homologous end joining in excitotoxicity: neuroprotective role of DNA-PKcs in kainic acid-induced seizures.  Hippocampus 15, 1057-1071.

 

4.       Narasimhaiah, R., Tuchman, A., Lin, S.L., and Naegele, J.R. (2005).  Oxidative damage and defective DNA repair is linked to apoptosis of migrating neurons and progenitors during cerebral cortex development in Ku70-deficient mice.  Cereb. Cortex 15, 696-707.

 

5.       Lin, S.L., Johnson-Farley, N.N., Lubinsky, D.R., and Cowen, D.S. (2003).  Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a cAMP-mediated, but protein kinase A-independent pathway utilizing EPAC-1.  J. Neurochem. 87, 1076-1085.

 

6.       Lin, S.L., Le, T.X., and Cowen, D.S. (2003).  SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation.  Cell. Microbiol. 5, 267-275.

 

7.       Lin, S.L., Setya, S., Johnson-Farley, N., and Cowen, D.S. (2002).  Differential coupling of 5-HT1 receptors to G proteins of the Gi family.  Brit. J. Pharmacol. 136, 1072-1078.

 

8.       King, I, Bermudes, D., Lin, S., Belcourt, M., Pike, J., Troy, K., Le, T., Ittensohn, M., Mao, J., Lang, W., Runyan, J.D., Luo, X., Li, Z., and Zheng, L.-m. (2002).  Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.  Hum. Gene Ther. 13, 1225-1233.

 

9.       Luo, X., Li, Z., Lin, S., Le, T., Ittensohn, M., Bermudes, D., Runyan, J.D., Shen, S.-y., Chen, J., King, I.C., and Zheng, L.-m. (2001).  Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models.  Oncol. Res. 12, 501-508.

 

10.    Jeffrey, P.L., Capes-Davis, A., Dunne, J., Tolhurst, O., Seeto, G., Hannan, A., and Lin, S.L. (2000).  CROC-4: a novel brain-specific transcriptional activator of c-fos expressed from proliferation through to maturation of multiple neuronal cell types.  Mol. Cell. Neurosci. 16, 185-196.

 

11.    Lione, A.M., Errico, M., Lin, S.L., and Cowen, D.S. (2000).  Activation of ERK1 and Akt by human serotonin 5-HT1B receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4.  J. Neurochem. 75, 934-938.

 

12.    Zheng, L.-m., Luo, X., Feng, M., Li, Z., Le, T., Ittensohn, M., Trailsmith, M., Bermudes, D., Lin, S.L., and King, I.C. (2000).  Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector.  Oncol. Res. 12, 127-135.

 

13.    King, I., Luo, X., Feng, M., Ittensohn, M., Li, Z., Belcourt, M., Lin, S., Le, T., Pike, J., Troy, K., Sznol, M., Clairmont, C., Bermudes, D., and Zheng, L.-m. (2000).  Tumor therapy using Salmonella.  Emerging Drugs 5, 211-219.

 

14.    Sznol, M., Lin, S.L., Bermudes, D., Zheng, L.-m., and King, I. (2000).  Use of preferentially-replicating Salmonella for the treatment of cancer.  J. Clin. Invest. 105, 1027-1030.

 

15.    Low, K.B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S.L., Luo, X., Miller, S.I., Zheng, L.-m., King, I., Pawalek, J.M., and Bermudes, D.  (1999).  Lipid A mutant Salmonella with suppressed virulence and TNF-a induction retain tumor-targeting in vivo.  Nature Biotech. 17, 37-41.

 

16.    Chen, S.-H., Lin, S.L., King, I., Spinka, T., Dutschman, G.E., Gullen, E.A., Cheng, Y.-C., and Doyle, T.W.  (1998).  Synthesis and comparative evaluation of two antiviral agents: §-L-FD4C and §-D-FD4C.  Bioorg. Med. Chem. Lett. 8, 3245-3250.

 

17.    Xiao, W., Lin, S.L., Broomfield, S., Chow, B.L., and Wei, Y.-F.  (1998).  The products of the yeast MMS2 and two human homologues (hMMS2 and CROC-1) define a structurally and functionally conserved Ubc-like protein family.  Nuc. Acids Res. 26, 3908-3914.

 

18.    Ma, L., Broomfield, S., Lavery, C., Lin, S.L., Xiao, W., and Bacchetti, S.  (1998).  Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumour-derived human cell lines.  Oncogene 17, 1321-1326.

 

19.    Sancho, E., Vila, M.R., Sanchez-Pulido, L., Lozano, J.J., Paciucci, R., Nadal, M., Fox, M., Harvey, C., Bercovich, B., Luokili, N., Ciechanover, A., Lin, S.L., Sanz, F., Estivill, X., Valencia, A., and Thomson, T.M.  (1998).  Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells.  Mol. Cell. Biol. 18, 576-589.

 

20.    Rothofsky, M.L. and Lin, S.L.  (1997).  CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter. Gene 195, 141-149.

 

21.    Kaminski, J.J., Rane, D.F., Snow, M.E., Weber, L., Rothofsky, M.L., Anderson, S.D., and Lin, S.L. (1997).  Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods.  J. Med. Chem. 40, 4103-4112.

 

22.    Chu, M., Truumees, I., Rothofsky, M.L., Patel, M.G., Gentile, F., Das, P.R., Puar, M.S., and Lin, S.L. (1995).  Inhibition of c-fos proto-oncogene induction by SCH52900 and SCH52901, novel diketopiperazines produced by Gliocladium sp.  J. Antibiot. 48, 1440-1445.

 

23.    Tamm, I., Lin, S.L., Pfeffer, L.M., and Sehgal, P.B. (1986).  Alpha and beta interferons as cellular regulatory molecules.  Interferon 9, 13-74.

 

24.    Lin, S.L., Schellekens, H., and Tamm, I. (1986).  Concomitant induction of a cytoskeleton-associated 76,000 d protein and inhibition of fluid-phase pinocytosis by interferon in Fujinami virus-transformed rat cells.  J. Interferon Res. 6, 563-572.

 

25.    Wang, E. and Lin, S.L. (1986).  Disappearance of statin, a protein marker for nonproliferating and senescent cells, following serum-stimulated cell cycle entry.  Exptl. Cell Res. 167, 135-143.

 

26.    Lin, S.L., Kikuchi, T., Pledger, W.J., and Tamm, I.  (1986).  Interferon inhibits the establishment of competence in Go/S phase transition.  Science 233, 356-359.

 

27.    Lin, S.L., Pledger, W.J., and Tamm, I.  (1986).  Interferon effects on platelet-derived growth factor (PDGF) action: inhibition of the PDGF-induced synthesis of a 29 kDa protein and of the dispersal of actin fibers.  In ÒThe Biology of the Interferon System 1985Ó.  W.E. Stewart and H. Schellekens, eds. Elsevier Science Publishers.  Amsterdam.  pp. 311-314.

 

28.    Lin, S.L., Garber, E.A., Wang, E., Caliguiri, L.A., Schellekens, H., Goldberg, A.R., and Tamm, I. (1983).  Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells.  Mol. Cell. Biol. 3, 1656-1664.

 

29.    Lin, S.L., TsÕo, P.O.P., and Hollenberg, M.D.  (1983).  Induction of 2Õ,5Õ-oligoadenylate synthetase, an interferon-related enzyme, by epidermal growth factor.  Life Sciences 32, 1479-1488.

 

30.    Lin, S.L., Greene, J.J., TsÕo, P.O.P., and Carter, W.A.  (1982).  Sensitivity and resistance of human tumour cells to interferon and rIn:rCn action.  Nature 297, 417-419.

 

31.    Lin, S.L., Takii, M., and TsÕo, P.O.P.  (1982).  Somatic mutation and neoplastic transformation induced by [methyl-3H]thymidine.  Radiat. Res. 90, 142-154.

 

32.    Lin, S.L., TsÕo, P.O.P., and Hollenberg, M.D.  (1980).  The effects of interferon on epidermal growth factor action.  Biochem. Biophys. Res. Commun. 96, 169-174.

 

33.    Meldrum, D.R., Dhopeshwarker, G.A., Lin, S.L., and Smith, M.L.  (1976).  Essential fatty acid deficiency with long-term hyperalimentation.  Gen. Oncol. 4, 66-69.

 

34.    Lin, S.L. and Chan, J.C.  (1973).  Urinary bicarbonate: a titrimetric method for determination.  Clin. Biochem. 6, 207-210.

 

35.    Chan, J.C., Asch, M.J., Lin, S.L., and Hayes, D.M.  (1972).  Hyperalimentation with amino acid and casein hydrolysate solutions.  Mechanism of acidosis.  J. Amer. Med. Asso. 220, 1700-1705.